Efficacy, Safety, and Adequacy of EUS-guided Liver Biopsy

Completed

Conditions studied: Chronic Hepatic, Liver Diseases

In brief

The purpose of this study is to evaluate the efficacy, safety, and adequacy of EUS-guided liver biopsy in patients undergoing EUS-guided liver biopsy at Methodist Dallas Medical Center (MDMC).

Key facts

Study ID

NCT04055870

Run by

Methodist Health System

People needed

24

Starts

2017-08-21

Expected to finish

2020-10-30

Last updated by the study team

2021-06-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 18 years or older
• Undergone EUS-guided liver biopsy at MDMC

You may not qualify if…

• Below 18 years of age
• Did not undergo EUS-guided liver biopsy at MDMC

Where it is running

• Methodist Dallas Medical Center — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.